Y Intercept (Hong Kong) LTD Alkermes Plc. Transaction History

Y Intercept (Hong Kong) LTD

  • $1.58 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$23.21 - $27.24 $876,850 - $1.03 Million
-37,779 Reduced 63.59%
21,631 $521,000
Q1 2024

May 10, 2024
BUY
$26.4 - $32.56 $1.57 Million - $1.93 Million
59,410 New
59,410 $1.61 Million
Q3 2023

Nov 14, 2023
BUY
$27.17 - $31.97 $962,035 - $1.13 Million
35,408 Added 308.3%
46,893 $1.31 Million
Q2 2023

Aug 14, 2023
BUY
$28.34 - $33.63 $325,484 - $386,240
11,485 New
11,485 $359,000
Q2 2022

Aug 08, 2022
BUY
$26.4 - $30.54 $297,475 - $344,124
11,268 New
11,268 $336,000

Others Institutions Holding ALKS

# of Institutions
361
Shares Held
181M
Call Options Held
175K
Put Options Held
96.6K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.73B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email